Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein Occlusion

Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein Occlusion - Intravitreal anti-VEGF for RVO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023005

Enrollment

100

Registered

2016-07-04

Start date

2016-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal vein occlusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patinets with retinal vein occlusion

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
visual acuity	—

Secondary

Measure	Time frame
intraocular pressure, central retinal thickness, Subfoveal choroidal thickness, non-perfusion area, electroretinography, recurrence of macular edema, smoking history	—

Countries

Japan

Contacts

Public ContactHiroyuki Kamao

Kawasaki Medical School Department of Ophthalmology

hironeri@med.kawasaki-m.ac.jp086-462-1111

Outcome results